Pre-existing low-frequency resistance mutations increase the risk of antiretroviral treatment failure in HIV-1 naïve patients.

MLA

Su, Yifan, et al. “Pre-Existing Low-Frequency Resistance Mutations Increase the Risk of Antiretroviral Treatment Failure in HIV-1 Naïve Patients.” Chinese Medical Journal, vol. 136, no. 22, Nov. 2023, pp. 2756–58. EBSCOhost, https://doi.org/10.1097/CM9.0000000000002901.

APA

Su, Y., Cai, R., Zhu, Y., Zhong, M., Qi, M., Chen, C., Ye, Z., Zhang, H., Wei, H., & Yin, Y. (2023). Pre-existing low-frequency resistance mutations increase the risk of antiretroviral treatment failure in HIV-1 naïve patients. Chinese Medical Journal, 136(22), 2756–2758. https://doi.org/10.1097/CM9.0000000000002901

Chicago

Su, Yifan, Rentian Cai, Yinyin Zhu, Mingli Zhong, Mingxue Qi, Chen Chen, Zi Ye, Hongying Zhang, Hongxia Wei, and Yanjie Yin. 2023. “Pre-Existing Low-Frequency Resistance Mutations Increase the Risk of Antiretroviral Treatment Failure in HIV-1 Naïve Patients.” Chinese Medical Journal 136 (22): 2756–58. doi:10.1097/CM9.0000000000002901.